Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study

Maurie Markman, John A. Blessing, Ronald D. Alvarez, Parviz Hanjani, Steven Waggoner, Kevin Hall

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences